Production (Stage)
Genmab A/S
GMAB
$22.82
-$0.27-1.17%
NASDAQ
03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
---|---|---|---|---|---|
Net Income | 1.56% | 441.45% | -39.29% | 4.15% | 534.55% |
Total Depreciation and Amortization | 23.08% | 96.28% | 32.95% | 23.63% | 329.64% |
Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
Total Other Non-Cash Items | 102.13% | -254.78% | 2,631.13% | 42.37% | -321.90% |
Change in Net Operating Assets | 22.95% | -28.00% | -403.55% | 53.62% | -85.18% |
Cash from Operations | 31.05% | 60.57% | 0.70% | 242.69% | -53.02% |
Capital Expenditure | -200.00% | -38.89% | 60.87% | 72.51% | 73.31% |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | 84.95% | 146.46% | -76.10% | 298.93% | -1,671.13% |
Cash from Investing | 79.52% | 118.37% | -77.58% | -372.08% | -11,111.36% |
Total Debt Issued | -- | -- | -- | -- | -- |
Total Debt Repaid | 33.33% | 100.00% | -6.25% | 34.48% | 85.71% |
Issuance of Common Stock | -88.89% | 22.22% | 7.50% | -77.46% | -71.88% |
Repurchase of Common Stock | 86.81% | -33.33% | -7,450.00% | -8,608.57% | 85.37% |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | -- | -- | -- | -- | -- |
Cash from Financing | 84.71% | 113.50% | -1,492.45% | -43,141.51% | 3.45% |
Foreign Exchange rate Adjustments | 900.00% | 215.93% | -90.94% | -30.18% | 96.79% |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | 410.39% | 485.98% | -40.30% | -622.07% | -122.31% |